Bellerophon Therapeutics Inc (NASDAQ:BLPH)

11.85
Delayed Data
As of Aug 14
 -0.40 / -3.27%
Today’s Change
3.19
Today|||52-Week Range
26.00
+125.91%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization377.0K400.0K373.0K362.0K
 
 
 
 
 
 
Operating ExpensesGross Income-377.0K-400.0K-373.0K-362.0K
 
 
 
 
 
General Expenses46.5M23.7M24.2M27.5M
 
 
 
 
 
Research And Development27.0M14.8M16.8M18.9M
 
 
 
 
 
Total Operating Expenses46.9M24.1M24.6M27.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-46.9M-24.1M-24.6M-27.9M
 
 
 
 
 
Extraordinary Credit0.00352.0K0.0024.9M
 
 
 
Extraordinary Charge-1.4M-590.0K-30.4M0.00
 
 
 
 
Other Expenses1.7M0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-46.5M-24.3M-54.8M-2.6M
 
 
 
 
 
Income Taxes0.00-438.0K0.00-5.4M
 
 
 
Net Income-46.5M-23.8M-54.8M2.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS12.3M15.1M39.0M57.4M
 
 
 
 
 
Shares To Calculate EPS Diluted12.3M15.1M39.0M65.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$3.79-$1.58-$1.41-$0.34
 
 
 
 
 
EPS Diluted-$3.79-$1.58-$1.41$0.04